Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015312532> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2015312532 abstract "Intrinsic and acquired resistance to antineoplastic agents continues to be a major clinical impediment to successful treatment of cancer in general, and breast cancer in particular. For example, about 40% of ER-positive metastatic breast tumors fail to respond to tamoxifen therapy, and of those that initially respond many will eventually develop resistance. Similarly, taxanes used as a first-line chemotherapy agent will have a response rate of 50%, which comes down to 20–30% in second- or third-line chemotherapy; nearly half of the treated subjects do not respond to it and suffer side effects. These facts underscore the importance of understanding the mechanism of resistance, which is crucial for the optimal systemic therapy of breast cancer. Unfortunately, in spite of extensive inquiry in this field, little is known about the key molecules/signaling pathways that regulate this phenomenon. Recently, we have discovered that small non-coding RNAs, i.e. microRNA (miRNAs), may play a critical role in mediating drug resistance in breast cancers. We have identified miRNAs that are differentially expressed between drug-resistant and sensitive breast cancer cells. Specifically, we have combined a high-throughput screening platform with a library of chemically synthesized inhibitors for all known human miRNAs and identified specific miRNA that selectively sensitize/de-sensitize drug-resistant breast cancer cells to either tamoxifen or trastuzumab (herceptin), drugs that are commonly used as a first line treatment for ER-positive and Her2-positive breast cancers, respectively. We identified 10 and 12 miRNA inhibitors that sensitized resistant cells to tamoxifen and trastuzumab, respectively. Interestingly, expression of cognate miRNA/s that sensitize resistant tumors to drug-induced cell death in our screen was found to be lower in relapsed (drug-resistant) metastatic breast cancer patients compared to normal matched control. In addition to tumor tissues, the levels of sensitizer miRNA/s in the blood sera of relapsed metastatic breast cancer patients was found to be dramatically lower than that of normal healthy individual. These findings are significant as it suggests that miRNAs can be efficiently detected in blood serum and therefore, can be used as a potential biomarker for predicting treatment outcomes. In addition, miRNAs may provide novel therapeutic tools for the treatment of drug-resistant breast cancers. Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P4-07-10." @default.
- W2015312532 created "2016-06-24" @default.
- W2015312532 creator A5000581778 @default.
- W2015312532 creator A5002711499 @default.
- W2015312532 creator A5005644569 @default.
- W2015312532 creator A5037952411 @default.
- W2015312532 creator A5059637384 @default.
- W2015312532 date "2013-12-15" @default.
- W2015312532 modified "2023-09-26" @default.
- W2015312532 title "Abstract P4-07-10: MicroRNAs as biomarkers and therapeutic adjuvants for the prognosis and treatment of drug-resistant breast cancers" @default.
- W2015312532 doi "https://doi.org/10.1158/0008-5472.sabcs13-p4-07-10" @default.
- W2015312532 hasPublicationYear "2013" @default.
- W2015312532 type Work @default.
- W2015312532 sameAs 2015312532 @default.
- W2015312532 citedByCount "0" @default.
- W2015312532 crossrefType "proceedings-article" @default.
- W2015312532 hasAuthorship W2015312532A5000581778 @default.
- W2015312532 hasAuthorship W2015312532A5002711499 @default.
- W2015312532 hasAuthorship W2015312532A5005644569 @default.
- W2015312532 hasAuthorship W2015312532A5037952411 @default.
- W2015312532 hasAuthorship W2015312532A5059637384 @default.
- W2015312532 hasConcept C104317684 @default.
- W2015312532 hasConcept C114851261 @default.
- W2015312532 hasConcept C121608353 @default.
- W2015312532 hasConcept C126322002 @default.
- W2015312532 hasConcept C143998085 @default.
- W2015312532 hasConcept C145059251 @default.
- W2015312532 hasConcept C2776694085 @default.
- W2015312532 hasConcept C2777176818 @default.
- W2015312532 hasConcept C2779786085 @default.
- W2015312532 hasConcept C2780035454 @default.
- W2015312532 hasConcept C502942594 @default.
- W2015312532 hasConcept C530470458 @default.
- W2015312532 hasConcept C55493867 @default.
- W2015312532 hasConcept C60644358 @default.
- W2015312532 hasConcept C71924100 @default.
- W2015312532 hasConcept C86803240 @default.
- W2015312532 hasConcept C89423630 @default.
- W2015312532 hasConcept C98274493 @default.
- W2015312532 hasConceptScore W2015312532C104317684 @default.
- W2015312532 hasConceptScore W2015312532C114851261 @default.
- W2015312532 hasConceptScore W2015312532C121608353 @default.
- W2015312532 hasConceptScore W2015312532C126322002 @default.
- W2015312532 hasConceptScore W2015312532C143998085 @default.
- W2015312532 hasConceptScore W2015312532C145059251 @default.
- W2015312532 hasConceptScore W2015312532C2776694085 @default.
- W2015312532 hasConceptScore W2015312532C2777176818 @default.
- W2015312532 hasConceptScore W2015312532C2779786085 @default.
- W2015312532 hasConceptScore W2015312532C2780035454 @default.
- W2015312532 hasConceptScore W2015312532C502942594 @default.
- W2015312532 hasConceptScore W2015312532C530470458 @default.
- W2015312532 hasConceptScore W2015312532C55493867 @default.
- W2015312532 hasConceptScore W2015312532C60644358 @default.
- W2015312532 hasConceptScore W2015312532C71924100 @default.
- W2015312532 hasConceptScore W2015312532C86803240 @default.
- W2015312532 hasConceptScore W2015312532C89423630 @default.
- W2015312532 hasConceptScore W2015312532C98274493 @default.
- W2015312532 hasLocation W20153125321 @default.
- W2015312532 hasOpenAccess W2015312532 @default.
- W2015312532 hasPrimaryLocation W20153125321 @default.
- W2015312532 hasRelatedWork W196872607 @default.
- W2015312532 hasRelatedWork W1988208622 @default.
- W2015312532 hasRelatedWork W2021603818 @default.
- W2015312532 hasRelatedWork W2103920551 @default.
- W2015312532 hasRelatedWork W2327243976 @default.
- W2015312532 hasRelatedWork W2380738254 @default.
- W2015312532 hasRelatedWork W2547984455 @default.
- W2015312532 hasRelatedWork W2593182413 @default.
- W2015312532 hasRelatedWork W2793989844 @default.
- W2015312532 hasRelatedWork W2892919148 @default.
- W2015312532 hasRelatedWork W2916613753 @default.
- W2015312532 hasRelatedWork W2970187888 @default.
- W2015312532 hasRelatedWork W3009947263 @default.
- W2015312532 hasRelatedWork W3012389413 @default.
- W2015312532 hasRelatedWork W3083193773 @default.
- W2015312532 hasRelatedWork W3092271262 @default.
- W2015312532 hasRelatedWork W3107225377 @default.
- W2015312532 hasRelatedWork W3142592018 @default.
- W2015312532 hasRelatedWork W3184588662 @default.
- W2015312532 hasRelatedWork W85527999 @default.
- W2015312532 isParatext "false" @default.
- W2015312532 isRetracted "false" @default.
- W2015312532 magId "2015312532" @default.
- W2015312532 workType "article" @default.